Dr. Sochacki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
145 Michigan St.
Grand Rapids, MI 49503
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2014 - 2017
- Michigan State University College of Human MedicineClass of 2014
Certifications & Licensure
- MI State Medical License 2019 - 2025
- TN State Medical License 2016 - 2021
- AL State Medical License 2020 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Chief Fellow - Hematology/Oncology Vanderbilt Ingram Cancer Center, 2019-2020
- Inductee Alpha Omega Alpha Honor Medical Society
Clinical Trials
- Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML Start of enrollment: 2022 Mar 17
- Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets Start of enrollment: 2023 Apr 04
- Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) Start of enrollment: 2023 Nov 13
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsDriver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk.Ashwin Kishtagari, M A Wasay Khan, Yajing Li, Caitlyn Vlasschaert, Naimisha Marneni
Blood Cancer Journal. 2024-01-15 - 38 citationsMutational landscape of myelodysplastic/myeloproliferative neoplasm–unclassifiablePrithviraj Bose, Aziz Nazha, Rami S. Komrokji, Keyur P. Patel, Sherry Pierce
Blood. 2018-11-08 - 5 citationsTherapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes.Andrew Sochacki, Melissa A. Fischer, Michael R. Savona
Oncotargets and Therapy. 2016-04-15
Journal Articles
- Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood
Abstracts/Posters
- Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase...Andrew Sochacki, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Next generation myelofibrosis risk analysis in the electronic health record.Andrew L. Sochacki, Cosmin Adrian Bejan, Shilin Zhao, Travis Spaulding, Thomas Stricker, Yaomin Xu, Michael R. Savona, American Society of Hematology Annual Meeting, San Diego, California, 12/2018
- Identification of myelofibrosis from electronic health records with novel algorithms and JAKextractor.Cosmin Adrian Bejan, Andrew Sochacki, Shilin Zhao, Yaomin Xu, Michael Savona, Proceedings of the Annual Meeting of the American Association for Cancer Research, Chicago, Illinois, 4/2018
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: